Post-Marketing Surveillance

Do you understand the complexity of Post-marketing Surveillance?

Date icon

23 - 25 Oct 2024

Attendance icon

On location

Language icon

English

Price icon
20,100 DKK ex VAT

(app. 2,702 EUR ex VAT)

50% DISCOUNT FOR PUBLIC INSTITUTIONS

Summary

This three day course will help you understand the different aspects of post-marketing surveillance, risk management planning, post-authorization safety studies, and signal management process tools for signal detection, interpretation and handling of findings.

After the course, you will be able to analyze and interpret signals and findings. You will also know how to use and prepare risk management plans, update Summary of Product Characteristics (SPCs), execute recalls, and manage a product life cycle.

The course is offered every 1 1/2 years.


Other course participants say

"It's a great course, it keeps its promises regarding the summary and keywords found on Atrium’s website. The presenters are highly engaged and provide interesting points of view."

Katharina Karlsson. Pharmacovigilance Specialist, Viatris A/S


"The course gives you a good overview of signal management, PSUR and RMP which are important tools in PV. It is good to hear the points of view of both the industry and authorities."

Sana Iqbal, Pharmacovigilance Manager, Billev Pharma ApS


    Keywords

    • Pharmacovigilance Legislation and Guidance Documents
    • Signal Management
    • Periodic Safety Update Report (PSUR) and Risk Management Systems
    • Signal Detection
    • Crisis Management
    • Risk Communication
    • Product Life Cycle Management
    • New Transparency Tools

      Hi! 

      Do you need help choosing the right course? 

      We are ready to help you at +45 39 27 60 60 or contact@atriumcph.com 

      Stay tuned with Atrium's newsletter 


    Save information for later
    Read more

    Course leader & lecturers

    • Cecilie Freddie Lange
      Course leader
      Manager, Safety Surveillance Oral Semaglutide
      Novo Nordisk A/S
    • Charlotta Thörn Jørgensen
      Lecturer

      Ferring Pharmaceuticals A/S
    • Maurizio Sessa
      Lecturer
      Assistant Professor of Pharmacoepidemiology
      Københavns Universitet
    • Per Sindahl
      Lecturer
      Safety officer
      Lægemiddelstyrelsen
    • Hanna Belcik Christensen
      Lecturer
      Pharmacovigilance Officer
      Lægemiddelstyrelsen
    • Atheline Major-Pedersen
      Lecturer
      Safety Surveillance Principal Specialist, Global Safety
      Novo Nordisk A/S
    • Jesper Hallas
      Lecturer
      Professor in Clinical Pharmacology
      Syddansk Universitet
    • Karsten Lollike
      Lecturer
      Director
      Novo Nordisk A/S - Novo Allé
    • Marianne Hald Clemmensen
      Lecturer
      Chef, Klinisk Farmaci – Rigshospitalet og Bornholm
      Region Hovedstaden
    See all

    Is this course for you?

    Whether you are new to the field or have several years of experience, this programme is relevant if you are a pharmacovigilance professional who wants to improve your knowledge and skills.

    What you will learn

    1. The different aspects of post-marketing surveillance
    2. How to analyze and interpret signals and findings
    3. How to use and prepare risk management plans, update SPCs, execute recalls and manage a product life cycle
    4. How to share knowledge in relation to post-marketing surveillance
    5. How to operate in a dynamic and changing environment

    What your company will get

    1. A safety and pharmacovigilance professional who understands the different aspects of post-marketing surveillance
    2. A safety and pharmacovigilance professional who can independently analyze and interpret signals and findings
    3. A safety and pharmacovigilance professional who can provide valuable input to all other team members working with post-marketing surveillance

    Course calendar

    Starting 23 Oct 2024
    23 Oct 2024 9:00-16:30
    Day 1
    • Current pharmacovigilance legislative framework and guidelines
    • Signal management process from a Marketing
    • Authorisation Holder’s (MAH) perspective
    • Tools for signal detection
    • Signal management process from a regulatory authority’s perspective
    • Workshop - Signal detection
    24 Oct 2024 9:00-16:00
    Day 2
    • PSUR Guidance
    • PSUR handling and assessment
    • Risk Management Plans (RMPs)
    • Post Authorization Safety Studies (PASS)
    • Pharmacoepidemiology in pharmacovigilance
    25 Oct 2024 9:00-16:00
    Day 3
    • Workshop - Crisis Management
    • Crisis management/Product Recalls
    • Executions of a recall
    • Effective risk communication
    • Impact assessment of pharmacovigilance – the PRAC strategy
    Practical information

    Related exams

    22 Nov 2024 10:00-13:00
    Go to exam page

    Registration

    Registration deadline
    16 Oct 2024
    Atrium
    Lersø Parkallé 101
    2100 København Ø
    Register
    23 - 25 Oct
    Sometimes things change. This is the expected programme.

    Course information

    Literature

    Prior to the course you will get access to mandatory and optional readings via your personal Atrium log-in.

    Please familiarize yourself with the mandatory readings before starting the course.

    The mandatory readings are also part of the examination syllabus.

    Prerequisites

    To enroll in this course, you must have a relevant educational background at bachelor level and, as a minimum, two years of experience in drug safety or pharmacovigilance, or other equivalent qualifications. We consider all applications upon registration.

    If you do not fulfill the requirements, you can still apply for the course if you have suitable experience in the pharmaceutical/biological area that would allow you to benefit from the training and enable you to participate actively during the module. Up to 10% of the positions on our course are filled by applicants who have no or limited experience in drug safety or pharmacovigilance. We consider applicants on a case-by-case basis.

    Examination

    The exam is held online, usually 4-6 weeks after the course.

    You will receive a link with exam questions via your personal Atrium log-in.

    In order to participate in the exam, you must have attended the course.

    This course is a part of a diploma

    Diploma in Pharmacovigilance

    The demand for qualified pharmacovigilance professionals is high. Become a sought after and highly valued professional by attending our pharmacovigilance training and acquire the Diploma in Pharmacovigilance.

    Read more

    Course leader

    Cecilie Freddie Lange
    Manager, Safety Surveillance Oral Semaglutide
    Novo Nordisk A/S

    Lecturers

    Charlotta Thörn Jørgensen

    Ferring Pharmaceuticals A/S
    Maurizio Sessa
    Assistant Professor of Pharmacoepidemiology
    Københavns Universitet
    Per Sindahl
    Safety officer
    Lægemiddelstyrelsen
    Hanna Belcik Christensen
    Pharmacovigilance Officer
    Lægemiddelstyrelsen
    Atheline Major-Pedersen
    Safety Surveillance Principal Specialist, Global Safety
    Novo Nordisk A/S
    Jesper Hallas
    Professor in Clinical Pharmacology
    Syddansk Universitet
    Karsten Lollike
    Director
    Novo Nordisk A/S - Novo Allé
    Marianne Hald Clemmensen
    Chef, Klinisk Farmaci – Rigshospitalet og Bornholm
    Region Hovedstaden

    You may also be interested in these courses

    Want to know more or need help?

    Contact Educational Programme Leader Lone Rex at +45 20 62 11 46

    Send me a message